Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance. Preprint.
GHDx Entry last modified on: May 12, 2022
COVID-19
Dataset Records for COVID-19
Displaying 1101 - 1150 of 1564
The Seroprevalence of COVID-19 in Intravenous Drug Users in Comparison to Non-drug Users
GHDx Entry last modified on: Mar 14, 2022
Temporal trends of SARS-CoV-2 seroprevalence in transfusion blood donors during the first wave of the COVID-19 epidemic in Kenya
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence and asymptomatic carrier status of SARS-CoV-2 in Wuhan City and other places of China
GHDx Entry last modified on: Jan 31, 2024
SARS-CoV-2 has been circulating in northeastern Brazil since February 2020: evidence for antibody detection in asymptomatic patients
GHDx Entry last modified on: Mar 14, 2022
Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel
GHDx Entry last modified on: May 12, 2022
Prevalence of SARS-CoV-2 Among Patients Admitted for Childbirth in Southern Connecticut
GHDx Entry last modified on: Jan 31, 2024
Medium-term impact of COVID-19 on pulmonary function, functional capacity and quality of life
GHDx Entry last modified on: Apr 10, 2023
Post-acute COVID-19 outcomes in children with mild and asymptomatic disease
GHDx Entry last modified on: Apr 10, 2023
SARS-CoV-2 seroprevalence and associated factors in Manaus, Brazil: baseline results from the DETECTCoV-19 cohort study
GHDx Entry last modified on: Jan 31, 2024
Low SARS-CoV-2 seroprevalence in the Austrian capital after an early governmental lockdown
GHDx Entry last modified on: Mar 14, 2022
Patient-Reported Outcome Measures After Hospitalization During the COVID-19 Pandemic: A Survey Among COVID-19 and Non-COVID-19 Patients
GHDx Entry last modified on: Apr 10, 2023
Coronavirus Disease 2019 (COVID-19) Seropositivity and Asymptomatic Rates in Healthcare Workers Are Associated with Job Function and Masking
GHDx Entry last modified on: Jan 31, 2024
Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic
GHDx Entry last modified on: Jan 31, 2024
Prevalence of SARS-CoV-2 Antibodies after First 6 Months of COVID-19 Pandemic, Portugal
GHDx Entry last modified on: May 12, 2022
Seroprevalence of anti-SARS-CoV-2 antibodies and risk factors among healthy blood donors in Luanda, Angola
GHDx Entry last modified on: Apr 8, 2022
SARS-CoV-2 seroprevalence in Mongolia: Results from a national population survey
GHDx Entry last modified on: Mar 14, 2022
COVID-19 Pandemic Preparedness - Infection Rate and Infection Fatality Ratio Estimates 2020-2021
GHDx Entry last modified on: Jul 28, 2023
COVID-19 Excess Mortality Estimates 2020-2021
GHDx Entry last modified on: Apr 7, 2022
Risk factors for severe and critical Covid-19 in pregnant women in a single center in Brazil
GHDx Entry last modified on: Jan 31, 2024
Perinatal outcomes in women with severe acute respiratory syndrome coronavirus 2 infection: comparison with contemporary and matched pre-COVID-19 controls
GHDx Entry last modified on: Apr 10, 2023
SARS-CoV-2 infection in pregnant women and newborns in two maternity hospitals in Salvador-Bahia, Brazil
GHDx Entry last modified on: Jan 31, 2024
Clinical and epidemiological characteristics of mothers with COVID-19 and their neonates: vertical transmission
GHDx Entry last modified on: Apr 10, 2023
Risk factors for adverse outcomes among pregnant and postpartum women with acute respiratory distress syndrome due to COVID-19 in Brazil
GHDx Entry last modified on: Apr 10, 2023
Development Assistance for COVID-19 Vaccine Delivery 2020-2021
GHDx Entry last modified on: Mar 16, 2023
Post-COVID Condition in Adults and Children Living in the Same Household in Italy: A Prospective Cohort Study Using the ISARIC Global Follow-Up Protocol
GHDx Entry last modified on: Mar 22, 2024
Post-acute Sequelae of SARS-CoV-2 Infection: Do Indians Fare Better?
GHDx Entry last modified on: Mar 22, 2024
Potential factors related to post-COVID-19 persistent symptoms; Khorshid COVID cohort study
GHDx Entry last modified on: Mar 22, 2024
Two-Year Health Outcomes in Hospitalized COVID-19 Survivors in China
GHDx Entry last modified on: Mar 22, 2024
Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study
GHDx Entry last modified on: May 12, 2022
Estimation of seroprevalence of novel coronavirus disease (COVID-19) using preserved serum at an outpatient setting in Kobe, Japan: A cross-sectional study. Preprint
GHDx Entry last modified on: Mar 14, 2022
Recovery rate and factors associated with smell and taste disruption in patients with coronavirus disease 2019 [Pre-proof]
GHDx Entry last modified on: Mar 14, 2022
Olfactory and taste disorders in healthcare workers with COVID-19 infection
GHDx Entry last modified on: Mar 14, 2022
Coronavirus disease 2019 in pregnancy was associated with maternal morbidity and preterm birth
GHDx Entry last modified on: Mar 14, 2022
Analysis of vaginal delivery outcomes among pregnant women in Wuhan, China during the COVID-19 pandemic
GHDx Entry last modified on: Jan 31, 2024
Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study
GHDx Entry last modified on: Jan 31, 2024
Routine screening for SARS CoV-2 in unselected pregnant women at delivery
GHDx Entry last modified on: Mar 14, 2022
Antibody kinetics in primary- and secondary-care physicians with mild to moderate SARS-CoV-2 infection
GHDx Entry last modified on: Mar 14, 2022
Insights from a Pan India Sero-Epidemiological survey (Phenome-India Cohort) for SARS-CoV2. Preprint
GHDx Entry last modified on: May 12, 2022
Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study
GHDx Entry last modified on: Jan 31, 2024
Lessons from low seroprevalence of SARS-CoV-2 antibodies in schoolchildren: A cross-sectional study
GHDx Entry last modified on: Jun 17, 2021
Pregnancy and Perinatal Outcomes of Women With Coronavirus Disease (COVID-19) Pneumonia: A Preliminary Analysis
GHDx Entry last modified on: Jan 31, 2024
Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia. Preprint
GHDx Entry last modified on: Mar 14, 2022
Serologic response to SARS-CoV-2 in an African population
GHDx Entry last modified on: May 12, 2022
Assessment of Anti-SARS CoV-2 seroprevalence in habitants of Assam (AASSHA): report of the first serosurvey in Assam
GHDx Entry last modified on: Jan 31, 2024
Prevalence evolution of SARS-CoV-2 infection in the Municipality of São Paulo, 2020 - 2021
GHDx Entry last modified on: May 12, 2022
Patients With Uncomplicated Coronavirus Disease 2019 (COVID-19) Have Long-Term Persistent Symptoms and Functional Impairment Similar to Patients with Severe COVID-19: A Cautionary Tale During a Global Pandemic
GHDx Entry last modified on: Jan 31, 2024
High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 in eight municipalities of the Colombian tropics: high immunity, clinical and sociodemographic outcomes
GHDx Entry last modified on: Mar 14, 2022
Subscribe